Alumis Balance Sheet Health

Financial Health criteria checks 6/6

Alumis has a total shareholder equity of $348.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $412.6M and $64.2M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$361.87m
EquityUS$348.39m
Total liabilitiesUS$64.17m
Total assetsUS$412.56m

Recent financial health updates

No updates

Recent updates

Alumis: Could This Broken Immunology IPO Become The Next Amgen?

Oct 04

Alumis: Recent IPO With Differentiated Data In Autoimmune Diseases

Sep 16

Financial Position Analysis

Short Term Liabilities: ALMS's short term assets ($377.3M) exceed its short term liabilities ($33.5M).

Long Term Liabilities: ALMS's short term assets ($377.3M) exceed its long term liabilities ($30.7M).


Debt to Equity History and Analysis

Debt Level: ALMS is debt free.

Reducing Debt: ALMS has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ALMS has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: ALMS has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 33.7% each year.


Discover healthy companies